Stratec SE (FRA:SBS)

Market Cap	337.94M
Revenue (ttm)	257.62M
Net Income (ttm)	16.02M
Shares Out	n/a
EPS (ttm)	1.32
PE Ratio	21.09
Forward PE	15.33
Dividend	0.60 (2.11%)
Ex-Dividend Date	Jun 30, 2025

Volume	588
Average Volume	8,545
Open	28.55
Previous Close	28.40
Day's Range	28.10 - 28.55
52-Week Range	21.00 - 45.30
Beta	n/a
RSI	50.88
Earnings Date	Aug 19, 2025

About Stratec SE

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1...

• Industry: Laboratory Analytical Instruments
• Founded: 1979
• Employees: 1,387
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SBS

Financial Performance

In 2024, Stratec SE's revenue was 257.62 million, a decrease of -4.73% compared to the previous year's 270.41 million. Earnings were 16.02 million, an increase of 4.24%.